Manufacturer access to Rebate Reports.

(a) General. CMS will establish a method and process for a manufacturer of the Part D rebatable drug to: (1) Access the Rebate Report as set forth in §§ 428.401 and 428.402, including any report of a reconciled rebate amount as set forth in §§ 428.401 and 428.402; (2) Submit a Suggestion of Error as set forth in §§ 428.402(c) and 428.403; and (3) Pay a rebate amount as set forth in § 428.405. (b) [Reserved]